Clinical Trial Update: Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab in combination with neoadjuvant chemoradiotherapy for resectable esophageal cancer, specifically esophageal squamous cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Jianhua Fu | Conditions: Esophageal Squamous Cell Carcinoma by AJCC V8 Stage, Resectable Esophageal Cancer | Phase 2 | Status: UNKNOWN